141 related articles for article (PubMed ID: 9564847)
1. Amelioration of diabetes in nonobese diabetic mice with advanced disease by linomide-induced immunoregulation combined with Reg protein treatment.
Gross DJ; Weiss L; Reibstein I; van den Brand J; Okamoto H; Clark A; Slavin S
Endocrinology; 1998 May; 139(5):2369-74. PubMed ID: 9564847
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of diabetes in NOD mice with advanced disease by islet isografts following immunoregulation with Linomide (quinoline-3-carboxamide).
Slavin S; Weiss L; Xia W; Gross DJ
Cell Transplant; 1996; 5(6):627-30. PubMed ID: 8951220
[TBL] [Abstract][Full Text] [Related]
3. Prevention of diabetes mellitus in non-obese diabetic mice by Linomide, a novel immunomodulating drug.
Gross DJ; Sidi H; Weiss L; Kalland T; Rosenmann E; Slavin S
Diabetologia; 1994 Dec; 37(12):1195-201. PubMed ID: 7895948
[TBL] [Abstract][Full Text] [Related]
4. The immunomodulator Linomide: role in treatment and prevention of autoimmune diabetes mellitus.
Gross DJ; Weiss L; Reibstein I; Hedlund G; Dahlén E; Rapoport MJ; Slavin S
Int Immunopharmacol; 2001 Jun; 1(6):1131-9. PubMed ID: 11407307
[TBL] [Abstract][Full Text] [Related]
5. Prevention of autoimmune diabetes by linomide in nonobese diabetic (NOD) mice is associated with up-regulation of the TCR-mediated activation of p21(ras).
Rapoport MJ; Weiss L; Mor A; Bistritzer T; Ramot Y; Slavin S
J Immunol; 1996 Nov; 157(10):4721-5. PubMed ID: 8906854
[TBL] [Abstract][Full Text] [Related]
6. Loss of glucose transporter-2 precedes insulin loss in the nonobese diabetic and the low-dose streptozotocin mouse models: a comparative immunohistochemical study by light and confocal microscopy.
Reddy S; Young M; Poole CA; Ross JM
Gen Comp Endocrinol; 1998 Jul; 111(1):9-19. PubMed ID: 9653017
[TBL] [Abstract][Full Text] [Related]
7. IL-4 prevents insulitis and insulin-dependent diabetes mellitus in nonobese diabetic mice by potentiation of regulatory T helper-2 cell function.
Cameron MJ; Arreaza GA; Zucker P; Chensue SW; Strieter RM; Chakrabarti S; Delovitch TL
J Immunol; 1997 Nov; 159(10):4686-92. PubMed ID: 9366391
[TBL] [Abstract][Full Text] [Related]
8. The Reg gene family and Reg proteins: with special attention to the regeneration of pancreatic beta-cells.
Okamoto H
J Hepatobiliary Pancreat Surg; 1999; 6(3):254-62. PubMed ID: 10526060
[TBL] [Abstract][Full Text] [Related]
9. Prevention and treatment of type I diabetes in NOD mice by linomide.
Slavin S; Gross D; Weiss L
Transplant Proc; 1995 Dec; 27(6):3240. PubMed ID: 8539933
[No Abstract] [Full Text] [Related]
10. Linomide does not prevent spontaneous autoimmune thyroiditis in NOD mice.
Hartoft-Nielsen ML; Rasmussen AK; Kaas A; Bock T; Buschard K; Feldt-Rasmussen U
Autoimmunity; 2001; 33(2):79-84. PubMed ID: 11264786
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulation and regeneration of islet Beta cells by cytokines in autoimmune type 1 diabetes.
Singh B; Nikoopour E; Huszarik K; Elliott JF; Jevnikar AM
J Interferon Cytokine Res; 2011 Oct; 31(10):711-9. PubMed ID: 21851268
[TBL] [Abstract][Full Text] [Related]
12. Reg (regenerating) gene overexpression in islets from non-obese diabetic mice with accelerated diabetes: role of IFNbeta.
Planas R; Alba A; Carrillo J; Puertas MC; Ampudia R; Pastor X; Okamoto H; Takasawa S; Gurr W; Pujol-Borrell R; Verdaguer J; Vives-Pi M
Diabetologia; 2006 Oct; 49(10):2379-87. PubMed ID: 16900387
[TBL] [Abstract][Full Text] [Related]
13. Course of pancreatic beta cell destruction in prediabetic NOD mice: a histomorphometric evaluation.
Debussche X; Lormeau B; Boitard C; Toublanc M; Assan R
Diabete Metab; 1994; 20(3):282-90. PubMed ID: 8001717
[TBL] [Abstract][Full Text] [Related]
14. Oral administration of insulin to female nonobese diabetic mice inhibited diabetes and induced Fas ligand expression on islets of Langerhans.
Wang H; Li Y; Sun Q; Yang G
Chin Med J (Engl); 2000 May; 113(5):433-6. PubMed ID: 11776099
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant immunotherapy increases beta cell regenerative factor Reg2 in the pancreas of diabetic mice.
Huszarik K; Wright B; Keller C; Nikoopour E; Krougly O; Lee-Chan E; Qin HY; Cameron MJ; Gurr WK; Hill DJ; Sherwin RS; Kelvin DJ; Singh B
J Immunol; 2010 Nov; 185(9):5120-9. PubMed ID: 20876350
[TBL] [Abstract][Full Text] [Related]
16. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic beta-cell replication and amelioration of surgical diabetes by Reg protein.
Watanabe T; Yonemura Y; Yonekura H; Suzuki Y; Miyashita H; Sugiyama K; Moriizumi S; Unno M; Tanaka O; Kondo H
Proc Natl Acad Sci U S A; 1994 Apr; 91(9):3589-92. PubMed ID: 8170952
[TBL] [Abstract][Full Text] [Related]
18. Effect of Linomide on adhesion molecules, TNF-alpha, nitrogen oxide, and cell adhesion.
Abdul-Hai A; Hershkoviz R; Weiss L; Lider O; Slavin S
Int Immunopharmacol; 2005 Feb; 5(2):231-9. PubMed ID: 15652754
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic IL-4 expression results in islet-reactive Th2 cells that inhibit diabetogenic lymphocytes in the nonobese diabetic mouse.
Gallichan WS; Balasa B; Davies JD; Sarvetnick N
J Immunol; 1999 Aug; 163(3):1696-703. PubMed ID: 10415077
[TBL] [Abstract][Full Text] [Related]
20. Islet regeneration during the reversal of autoimmune diabetes in NOD mice.
Kodama S; Kühtreiber W; Fujimura S; Dale EA; Faustman DL
Science; 2003 Nov; 302(5648):1223-7. PubMed ID: 14615542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
